2-아미노-4-히드록시-5-나프탈렌디술폰산,디아조화2,7-(2-아미노페닐)-4H-벤즈이미다졸-1-아민및디아조화5-니트로벤젠아민과결합된벤조산,4-히드록시-,모노나트륨염,나트륨염

Sodium Salicylate

HCID 16760658

노트 반응

부분 구조 검색 유사 구조 찾기

기본 정보

CAS: 54-21-7
표준 SMILES: O=C([O-])c1ccccc1O.[Na+]
InChIKey: ABBQHOQBGMUPJH-UHFFFAOYSA-M
분자식: C7H5NaO3
평균 분자량: 160.1 g/mol
단동위원소 질량: 160.0136383

개요

Sodium salicylate is an organic molecular entity.

이름 및 식별자

우선 이름: Sodium Salicylate
IUPAC: sodium 2-hydroxybenzoate
현지명: 2-아미노-4-히드록시-5-나프탈렌디술폰산,디아조화2,7-(2-아미노페닐)-4H-벤즈이미다졸-1-아민및디아조화5-니트로벤젠아민과결합된벤조산,4-히드록시-,모노나트륨염,나트륨염
영어명: Benzoic acid, 2-hydroxy-, monosodium salt, coupled with 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, diazotized 2-(4-aminophenyl)-1H-benzimidazol-5-amine and diazotized 4-nitrobenzenamine, sodium salt
분자식: C7H5NaO3
분자량: 160.10257

이름 및 동의어

Sodium salicylate54-21-7EnterosalicylKerasalicylAlysineBenzoic acid, 2-hydroxy-, monosodium saltNatrum salicylicumSalicylic acid sodium saltsalicylate sodiumDTXSID5021708Monosodium 2-hydroxybenzoateNatrii salicylas

이름 더 보기

2-아미노-4-히드록시-5-나프탈렌디술폰산,디아조화2,7-(2-아미노페닐)-4H-벤즈이미다졸-1-아민및디아조화5-니트로벤젠아민과결합된벤조산,4-히드록시-,모노나트륨염,나트륨염Benzoic acid, 2-hydroxy-, monosodium salt, coupled with 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid, diazotized 2-(4-aminophenyl)-1H-benzimidazol-5-amine and diazotized 4-nitrobenzenamine, sodium salt

WIQ1H85SYPSalicylate, sodiumNSC-202167DTXCID701708Benzoic acid, 2-hydroxy-, sodium salt (1:1)NSC202167Sod salPro-Prin

데이터베이스 식별자

CAS: 54-21-7、90218-94-3
PubChem CID: 16760658
DTXSID: DTXSID5021708
ChEMBL: CHEMBL447868
ChEBI: CHEBI:9180
UNII: WIQ1H85SYP
EC Number: 200-198-0、290-774-8

물성

구조 계산 물성

극성 표면적: 60.4 Å²
수소 결합 공여자 수: 1
수소 결합 수용자 수: 3
회전 가능 결합 수: 1
무거운 원자 수: 11
형식 전하: 0
복잡도: 138

실험 및 물리화학적 성질

Cosmetics · 2건

Cosmetic ingredients (Sodium Salicylate) -> CIR (Cosmetic Ingredient Review)

Preservative

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List

Food Contact Substances · 4건

FCS -> FDA Cumulative Estimated Daily Intake (CEDI)

FCS -> FDA Inventory of Food Contact Substances Listed in 21 CFR

FCS -> FDA Inventory of Effective Food Contact Substance (FCS) Notifications

Physical DescriptionDry Powder

안전 및 규제

GHS 분류

GHS Classification · 6건

This chemical does not meet GHS hazard criteria for 0.7% (3 of 441) of reports.

Warning

H302 (96.4%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P318, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 441 reports by companies from 22 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

유해성 정보

Regulatory Information · 4건

Chemical: Benzoic acid, 2-hydroxy-, sodium salt (1:1)

Benzoic acid, 2-hydroxy-, sodium salt (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Benzoic acid, 2-hydroxy-, sodium salt (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

Status: Active Update: 17-06-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/13593

Sodium salicylate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Salicylic acid and its salts: Human health tier II assessment

Hazard Classes and Categories · 2건

Acute Tox. 4 (96.4%)

Acute toxicity - category 4

독성 정보

Toxicity Summary · 2건

The Panel concluded that the following ingredients are safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be non-irritating and non-sensitizing, which may be based on a quantitative risk assessment (QRA)...Sodium Salicylate...

Safe for use in cosmetics, with qualifications

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 2건

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.